JMP Securities initiates coverage on Enovis Corporation with a Market Outperform rating, highlighting its strategic acquisitions, including LimaCorporate, and future growth potential. The analyst notes the company's undervaluation and sees revenue catalysts ahead.
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024.
Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent acquisitions impact.
William Bliar has initiated coverage on Enovis Corp (NYSEENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth, especially in sub-categories such as extremities, which are growing rapidly due to
Enovis Corporation (NYSEENOV) shares are trading lower on Thursday after the company announced a proposed private offering of $400 million of convertible senior notes and issued
Needham initiated coverage on Enovis Corp (NYSEENOV) with a Buy and a price target of $70, noting that the company can sustain above-market growth in its Reconstructive segment via market share gains and acquisitions, which is expected to
